A multi-center study evaluating the safety of a replacement intravitreal fluocinolone acetonide (FA) (0.59 mg) implant in patients with non-infectious posterior uveitis who were previously treated with an intravitreal FA implant
Latest Information Update: 29 Jul 2020
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Posterior uveitis
- Focus Adverse reactions
- Sponsors Bausch & Lomb
Most Recent Events
- 29 Jul 2020 New trial record